Loading
Diagnosis information
Core diagnostic criteria, specifiers, differential considerations, and documentation support in one open, scan-friendly view.
All criteria are shown. No expand controls or hidden sections.
Core criterion A
Parkinsonian tremor, muscular rigidity, or akinesia developing in association with medication use (most commonly neuroleptic/antipsychotic or dopamine-depleting agent)
Core criterion B
Symptoms developed within a few weeks of starting or raising dose of causative medication
Consistent with [Medication-Induced Parkinsonism] [specifier(s)]. Following exposure to a dopamine-blocking or dopamine-depleting medication, there has been the development of bradykinesia; muscular rigidity; resting tremor; postural instability; masked facies; reduced arm swing; shuffling gait; hypophonia; micrographia, forming a parkinsonian syndrome that emerged during medication use or within a clinically plausible temporal relationship to exposure. The presentation is further characterised by onset temporally linked to medication exposure and partial or incomplete resolution despite dose reduction or cessation, or features not fully meeting criteria for classic idiopathic Parkinson's disease. These symptoms have resulted in clinically significant distress or impairment in motor, occupational, or daily functioning, and the disturbance does not occur exclusively during delirium.
Adapt this supplied template to the assessment. It is not a substitute for diagnostic reasoning or local documentation requirements.